×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
PR Newswire
Leap Therapeutics Reports First Quarter 2024 Financial Results. Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on...
2 months ago
Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
Yahoo Finance
Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted.
2 months ago
Leap Therapeutics Announces $40 Million Private Placement
PR Newswire
CAMBRIDGE, Mass., April 11, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. ... Leap anticipates the gross proceeds from the private placement will...
1 month ago
Leap Therapeutics Shares Rise 9% After Pricing of Private Placement
MarketWatch
By Chris Wack Leap Therapeutics shares were rose after the company entered a securities purchase agreement with a group of institutional...
1 month ago
Leap Therapeutics: The DisTinGuish Trial Provides A Near-Term Catalyst
Seeking Alpha
Leap Therapeutics is developing DKN-01, a drug with potential in multiple types of cancer. Read my earnings analysis of LPTX stock here.
3 weeks ago
H.C. Wainwright retains buy rating on Leap Therapeutics stock; cuts PT to $5.50 By Investing.com
Investing.com
Tuesday, Leap Therapeutics (NASDAQ:LPTX), a biopharmaceutical company, saw its stock price target reduced from $7.00 to $5.50 by H.C....
3 weeks ago
Leap Therapeutics Reports Third Quarter 2023 Financial Results
KGET.com
CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing...
6 months ago
Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update
Defense World
Read Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update at Defense World.
2 weeks ago
Leap Therapeutics' Success Tied to Partner NovaRock's Commitment in Asian Markets - TipRanks.com
Tipranks
Leap Therapeutics (LPTX) has disclosed a new risk, in the Supply Chain category. Leap Therapeutics' business risk hinges significantly on NovaRock...
2 months ago
Leap Therapeutics (NASDAQ:LPTX) Will Have To Spend Its Cash Wisely
Yahoo
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
2 weeks ago